Current Role and Emerging Evidence for Bruton Tyrosine Kinase Inhibitors in the Treatment of Mantle Cell Lymphoma
David A. Bond, Kami J. Maddocks
Topics & Concepts
IbrutinibMantle cell lymphomaBruton's tyrosine kinaseMedicineClinical trialTyrosine kinaseOncologyLymphomaInternal medicineCancer researchChronic lymphocytic leukemiaLeukemiaReceptorLymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia ResearchCNS Lymphoma Diagnosis and Treatment